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Abstract
S6 kinases (S6Ks) act to integrate nutrient and insulin signaling pathways and, as such, function as positive effectors in cell
growth and organismal development. However, they also have been shown to play a key role in limiting insulin signaling
and in mediating the autophagic response. To identify novel regulators of S6K signaling, we have used a Drosophila-based,
sensitized, gain-of-function genetic screen. Unexpectedly, one of the strongest enhancers to emerge from this screen was
the nuclear receptor (NR), Drosophila hormone receptor 3 (DHR3), a critical constituent in the coordination of Drosophila
metamorphosis. Here we demonstrate that DHR3, through dS6K, also acts to regulate cell-autonomous growth. Moreover,
we show that the ligand-binding domain (LBD) of DHR3 is essential for mediating this response. Consistent with these
findings, we have identified an endogenous DHR3 isoform that lacks the DBD. These results provide the first molecular link
between the dS6K pathway, critical in controlling nutrient-dependent growth, and that of DHR3, a major mediator of
ecdysone signaling, which, acting together, coordinate metamorphosis.
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Introduction
During development, cell growth arrests when organs reach
their appropriate size [1] such that differentiation acts to impede
further growth. However, the growth-regulating module can be
reactivated in specific cell types to maintain homeostasis in the
adult. Moreover, pathological settings, such as cancer and obesity,
can lead to aberrant activation of cell growth in a differentiated
setting [2]. Despite this understanding, we have little knowledge of
the molecular links that act to integrate differentiation programs
with those that control growth. In identifying the underlying
molecular mechanisms that regulate cell growth and differentia-
tion in mammals, Drosophila genetics has proved a powerful tool.
This is because many of the molecular components are
evolutionarily conserved, as are the regulatory pathways in which
they function [3]. In cell growth, such studies have been critical in
revealing the central role of the Target of Rapamycin (TOR) as an
effector of an insulin- and nutrient-signaling network that acts to
maintain cell, tissue, and organismal homeostasis [4]. The value of
Drosophila genetics in such studies was initially demonstrated in the
identification of the genes responsible for Tuberous Sclerosis
Complex, dTsc1 (hamartin), and dTsc2 (tuberin), as negative
effectors of dTOR signaling [5–7] and subsequently the
identification of their target, the small GTPase Ras homologue
enriched in brain (dRheb) [8–10], a direct effector of TOR
signaling [11].
In Drosophila, both the insulin-related peptides (Dilps), acting
through the insulin receptor [12], and nutrients [13], such as
amino acids acting through their cognate transporters [14],
integrate at the level of dTOR to control cell growth [15,16]. A
key downstream effector of insulin- and nutrient-mediated dTOR-
dependent growth is the Drosophila ribosomal protein S6 kinase
(dS6K) [13,17]. Although loss of dS6K largely results in late larval
lethality, the few escapers that survive to adulthood are severely
delayed in development and exhibit pronounced defects in cell
size, with no effect on cell number [18]. Moreover, such mutants
express elevated levels of Protein Kinase B (PKB) activity [17],
which is mediated through a dS6K-negative feedback loop [15].
Although many of the effects of loss of dS6K appear to be
controlled in a cell-autonomous manner [17–19], it is known that
loss of the dS6K orthologue, S6K1, has humoral effects in the
mouse [20]. Consistent with these findings, depletion of the amino
acid transporter slimfast within the fat body (FB) reduces dS6K
activity and causes a global growth defect similar to that seen in
loss-of-dS6K mutants and nutritionally deprived Drosophila [14].
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ized in feeding and growth, increase their mass approximately 200
fold [21]. During this phase, endoreplicative tissues assume
specific physiological functions, whereas the imaginal discs grow
and proliferate [22]. At the termination of larval development,
overall growth and feeding ceases. However, with the onset of
metamorphosis, most of the endoreplicative organs are degraded,
whereas the imaginal discs grow and differentiate into adult
structures [23]. Metamorphosis is initiated by a peak in production
of the steroid hormone ecdysone, which induces the activation of a
cascade of nuclear receptors (NRs) [24] and the ensuing program
of tissue remodeling. During metamorphosis, the degradation of
the endoreplicative tissues, including the salivary gland and the
midgut, is initiated by autophagy [25], a cellular process in which
portions of cytoplasm are sequestered within double-membrane
vesicles known as autophagosomes before delivery to lysosomes for
degradation and recycling of cellular components [26]. Interest-
ingly, although the dTOR signaling pathway acts as a negative
effector of autophagy, there is evidence that dS6K promotes
rather than suppresses this response [27], revealing a mutual
dependency between these two pathways. Moreover, treatment
with rapamycin, the inhibitor of dTOR/dS6K activation, blocks
the production of ecdysone [28], which is mediated by
prothoracicotropic hormone (PTTH) [29]. Although a connection
between the signaling pathways induced by ecdysone and those
induced by nutrients has not yet been formally established, earlier
studies indicated that ecdysone antagonizes insulin and dTOR
signaling [30–33]. However, recent findings demonstrate that
during metamorphosis ecdysone also induces the fat body to
produce Dilp6, which mediates the growth and proliferation of
mitotic cells of the imaginal discs during the remodeling of tissues
[23,34].
In search of novel effectors of dS6K signaling, we have taken
advantage of a sensitized phenotype, such that ectopic expression
of dS6K within the developing dorsal wing compartment causes
the wing to bend down [18]. This phenotype is characterized by
an increase in the size of the dorsal wing blade, attributable to an
increase in cell size, which is mediated by the level of dS6K activity
[17,19]. Using this sensitized phenotype in a genome-wide genetic
screen, we have identified a number of potential effectors in dS6K
signaling. Unexpectedly, one of the strongest amongst these was
the NR DHR3, a critical signaling component in the coordination
of Drosophila metamorphosis. Moreover, we show that the ligand-
binding domain of DHR3 is essential in modulating dS6K-
regulated cell growth, which led us to the identification of a novel
isoform of DHR3, devoid of the DNA-binding domain.
Results
A screen for dS6K modulators
Imaginal discs are subdivided into compartments, with each
constituting an individual growth unit that differentiates into an
adult structure during metamorphosis [22]. In this context, ectopic
expression of dS6K within the developing dorsal wing compart-
ment, using the apterous-Gal4 (ap-Gal4) driver, induces a moderate
overgrowth in this unit [18] and a bending-down of the adult wing
(Figure 1A and 1B). Consistent with PDK1 being the mammalian
S6K1 activation-loop kinase [35,36], we have previously demon-
strated an enhanced bending-down of the adult wing by co-
expression of the Drosophila PDK1 (dPDK1), whereas expression of
dPDK1 alone had no effect on this phenotype [17]. Likewise, the
expression of particular phosphorylation-site mutants of dS6K that
would be predicted to increase or decrease the activation state of
dS6K, enhances or suppresses this phenotype, respectively [19].
These findings demonstrate that the bent-down wing phenotype
varies according to dS6K activation status, and prompted us to use
this sensitized phenotype in a gain-of-function genetic screen to
identify novel modulators of dS6K activity. We also found that
ectopic expression of an active form of the mammalian S6 Kinase
1, S6K1
dE/D3E [37], induced a bent-down wing phenotype
equivalent to that induced by dS6K (compare Figure 1B and
1C). Like dS6K, co-expression of S6K1
dE/D3E and dPDK1 led to
an enhancement of the bent-down wing phenotype, but not to the
extent observed with dS6K (data not shown). We reasoned that
this differential phenotype may represent dPDK1 specificity for
dS6K, a bona fide substrate, unlike S6K1
dE/D3E [17,38], and have
utilized this differential effect to increase the selectivity of the gain-
of-function screen (see below).
In the screen, approximately five thousand Enhancer-Promoter
(EP) bi-directional insertions were co-induced with dS6K in the
developing dorsal wing compartment [39] and then scored for
either enhancement or suppression of the dS6K-dependent bent-
down wing phenotype. Approximately 1000 of the EP lines either
acting as suppressors (,90%) or enhancers (,10%), were further
analyzed for their effects on the bent-down wing phenotype when
induced alone or with the ap-Gal4 driver. In this way, nonspecific
effectors, which alone could induce the bent-wing phenotype, were
eliminated (data not shown), allowing us to narrow down the
potential candidates to 220 lines. These were then tested in the
tertiary screen in combination with either dS6K or the active
S6K1
dE/D3E, such that 19 suppressor and 76 enhancer lines were
retained (Table S1), 71 of which were localized by reverse PCR
mapping. We focused on the 76 enhancer lines, which were largely
confirmed through the three screening steps. Of these, 19 were not
considered because they interfered with wing development (Table
S1), including perturbation of vein formation, compartment
adhesion (Blister phenotype in Table S1), or the bending down
of the wing along the anterior-posterior axis (Figure S1). Among
the 57 enhancer lines selected through this process, the candidate
list was further narrowed to the strongest 21 enhancers (Table S1),
of which 18 induced a more severe phenotype with dS6K than
with S6K1
dE/D3E.
Author Summary
In biological systems, the execution of morphogenic
programs requires coordinated integration of the essential
processes of growth, proliferation, and differentiation.
Signaling networks embedded within these processes
include the insulin and nutrient pathways required for cell
growth and the steroid hormone-regulated pathways that
control discrete developmental steps. Although these
pathways are known to be integrated and coordinated,
the molecular bridges that link them remain to be
identified. Taking advantage of Drosophila, we performed
a genetic screen for novel regulators of the dS6K, which
previously has been identified as a key effector of cell
growth downstream of insulin and nutrient signaling.
Unexpectedly, we identified the nuclear receptor DHR3, a
key regulator of morphogenesis, as a potent modulator of
dS6K–mediated cell growth. Nuclear receptors typically
comprise a DNA–binding domain and a regulatory ligand-
binding domain. Here we show that a DHR3 isoform,
devoid of the DNA–binding domain is sufficient to
potentiate dS6K–mediated cell growth through its li-
gand-binding domain. We further demonstrate that, like
dS6K, DHR3 regulates cell-autonomous growth. These data
provide a unique molecular link between steroid-regulated
development and nutrient-dependent growth.
DHR3 Regulates dS6K-Dependent Growth
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That the 18 strong enhancers represented authentic dS6K
interacters was supported by the finding that 9 of the enhancers
were localized as independent insertions in the dPDK1 locus (Table
S1). Genomic mapping of the additional strong enhancers led to the
identification of 5 novel loci. Of these, we focused our attention on
EP lines EP12.218 and EP23.014 (Figure S2), which were inserted
in the DHR3 locus, coding for a nuclear receptor (CG33183), and
are collectively referred to as DHR3-EP. Inductionof either of these
EPlinesalone,usingthe ap-Gal4driver,waswithoutvisible effecton
wing development (Figure 1D and data not shown); whereas, in
combination with dS6K or S6K1
dE/D3E both EP lines induced a
strong enhancement of the bent-down wing phenotype (compare
Figure 1B and 1C with Figure 1E and 1F, respectively, and data not
shown). As the EP element employed in the screen contained two
UAS promoters to direct transcription in opposite directions [39],
the DHR3-EP could, theoretically, induce transcription of either
DHR3 or the histidine-decarboxylase gene (CG3454). As the UAS
promoter driving the latter gene was flanked by loxp sequences,
induction of Cre recombinase was used to excise this promoter in
the EP23.014 line. The resulting unidirectional EP line retained the
ability to enhance the dS6K-induced bent-down wing phenotype
(Figure 1J) arguing that the EPs mediate their effects through
DHR3. Using this same approach, we determined that the four
additional loci most likely regulate the expression of rab40
(CG1900), involved in vesicle trafficking; peste, encoding a scavenger
protein (CG7228); orb2,aCytoplasmic-Polyadenylation-Element-
Binding(CPEB)protein (CG5735);and hephaestus,aPolypyrimidine-
Track-Binding (PTB) protein (CG31000) (Table S1).
As both DHR3-EP elements are inserted within the first intron
of the DHR3 gene (see below), it is most likely that the enhanced
bent-down wing phenotype results from either inhibiting or
increasing the expression of DHR3. We therefore generated
inducible UAS-RNA-interference lines (DHR3-RNAi) to specifi-
cally reduce DHR3 expression. Induction of the DHR3-RNAi
alone by ap-Gal4 caused a bending up of the wing (Figure 1G),
indicating that normal growth of the dorsal wing blade is restricted
when DHR3 expression is suppressed. Further supporting this
observation, when co-induced in the dorsal wing compartment
with either dS6K alone or in combination with DHR3-EP, the
DHR3-RNAi completely suppressed the bent-down wing pheno-
type in both settings (Figure 1H and 1K). These findings indicate
that the positive genetic interaction observed with dS6K is due to
increased expression of the DHR3 gene product. Although we
found that co-expression of DHR3-EP and S6K1
dE/D3E enhanced
the bent-down wing phenotype (Figure 1C and 1F), this was to a
lesser degree than when co-expressed with dS6K (compare
Figure 1E and 1F), suggesting that DHR3, like dPDK1, acts
specifically on dS6K signaling. Consistent with this interpretation,
DHR3-RNAi suppressed the bent-down wing phenotype induced
by dS6K more strongly than that of S6K1
dE/D3E (compare
Figure 1H and 1I). Taken together, these differential effects
indicate that S6K1
dE/D3E is less sensitive than dS6K to relative
changes in the dosage of DHR3 and favor a specific role for
DHR3 in dS6K-dependent growth.
DHR3–EP reverses the inhibitory effects of dTsc1/2, but
not dPTEN, on growth
Recently, it has been suggested that the nutrient-effector arm of
the TOR signaling pathway may have been integrated with that of
the insulin-PI3K pathway following the rise of multicellular
organisms [40]. Although it is clear that the nutrient and insulin
Figure 1. DHR3 is a specific dS6K interacter. Induction of UAS constructs and EPs by the ap promoter directed Gal4 expression within the dorsal
compartment of the wing imaginal disc: (A) ap-Gal4 control; (B, E, H, J, K) UAS-dS6K; (C, F, I) UAS-S6K1
dE/D3E; (D, E, F) DHR3-EP; (G, H, I, K) UAS-DHR3-
RNAi and (J) unidirectional DHR3-EP. The bending down of the wing indicates a slight overgrowth of the dorsal compartment, whereas a bending up
reveals a slight growth deficit of this compartment.
doi:10.1371/journal.pgen.1000937.g001
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point of integration resides [15,17]. In part, this lack of clarity
resides in the finding that depletion dTsc1/2, but not dPTEN,
leads to dS6K activation, and that the overgrowth phenotype
caused by loss of dTsc1/2, but not of dPTEN, is abolished by loss
of dS6K [17]. Consistent with these findings, when either tumor
suppressor is ectopically expressed in the developing eye, they
suppress growth of this compartment, with co-expression of dS6K
counteracting only the effects of dTsc1/2, but not of dPTEN (data
not shown). This difference allows us to test whether DHR3-EP is
acting exclusively on the dTsc1/2 growth response. As stated
above, ectopic expression of either dTsc1/2 or dPTEN suppressed
the growth of the developing eye (compare Figure 2A–2C). In
contrast, ectopic expression of DHR3-EP had no apparent impact
on eye development (compare Figure 2A and 2D), similar to what
was observed in the wing (Figure 1D). However, ectopic
expression of DHR3-EP, combined with either dTsc1/2 or
dPTEN, largely counteracted the growth-suppressive effects due
to dTsc1/2, but not of dPTEN (compare Figure 2E and 2B, and
Figure 2F with 2C). These results support the notion that DHR3
acts to promote dS6K signaling.
DHR3 is known to play a central role in coordinating
metamorphosis [41,42]; however, when DHR3-RNAi was ex-
pressed in the dorsal wing compartment it led to a decrease in the
size of the dorsal wing blade, causing the wing to bend upwards,
with no obvious detrimental effect on the differentiation of the
wing (Figure 1G). In agreement with this finding, DHR3-EP
suppressed the growth defect induced by overexpression of dTsc1/
2 in the eye, without altering differentiation of this organ
(Figure 2E). These findings were unexpected as they suggest that
DHR3 is not only involved in fate decisions associated with
differentiation, but that it may also play an integrative role in
controlling cell growth. Both EP elements were inserted within the
large first intron of DHR3, and failed to complement previously
reported DHR3 mutants (Figure 3A and Figure S2; Table S2).
However, in contrast to these previously described DHR3
mutants, which are lethal during early development, homozygous
and trans-heterozygous DHR3-EP insertions are semilethal (data
not shown), indicating that they represent hypomorphic DHR3
mutants. The few larvae that underwent metamorphosis were
delayed (data not shown) and exhibited a significant reduction in
body weight (Figure S3). The adult escapers emerged with an
approximate 2-day delay, and displayed female sterility. A
reduction in body weight and developmental delay have been
reported for a number of other mutants that affect growth, further
supporting a role for DHR3 in controlling this process [18,43].
Consistent with this observation, we also found that ubiquitous
suppression of DHR3 by RNAi provoked larval death, but also
provoked a significant developmental delay (data not shown).
Taken together, these findings imply that DHR3 has a distinct
function in controlling cell growth, potentially through dS6K.
The DHR3 protein that interacts with dSK6 lacks a DBD
DHR3 is a NR that classically comprises an amino-terminal
DNA-binding-domain (DBD) and a carboxyl-terminal ligand-
binding domain (LBD), separated by a linker domain [44]. The
FlyBase Consortium [45] first reported two potential transcripts
for DHR3 termed RA and RB (‘‘R’’ stands for RNA, whereas ‘‘P’’
denotes the corresponding protein) (Figure 3A), though, more
recently, two additional transcripts, RC and RD, have been listed.
Figure 2. DHR3–EP specifically counteracts Tsc-dependent growth suppression. Induction of UAS constructs and DHR3-EP by the eyeless
promoter-directed Gal4 expression in the developing eye: (A) eye-Gal4 control; (B, D, E) DHR3-EP; (C, D) UAS-dTsc1 and UAS-dTsc2; (E, F) UAS-dPTEN.
doi:10.1371/journal.pgen.1000937.g002
DHR3 Regulates dS6K-Dependent Growth
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located at specific alternative upstream first exons (Figure 3A and
data not shown). To identify the DHR3 gene product responsible
for the genetic interaction with dS6K, RACE (rapid amplification
of cDNA ends)-PCR has been performed using wild-type and
DHR3-EP larvae ubiquitously induced by a daughterless-Gal4 driver
(da-Gal4). The transcript identified for the latter was a splice
variant extending from the EP to the DHR3 second exon, and
lacking an AUG initiator codon upstream of the sequences
encoding the DBD (R-EP in Figure 3A and Figure S2). In addition
to previously described mRNAs, RACE-PCR experiments using
wild-type larvae revealed a novel DHR3 transcript lacking a first
alternative exon (RS, where S stands for short, Figure 3A and
Figure S2). This transcript would be predicted to encode a DHR3-
PS protein that is devoid of the DBD, as the most proximal AUG
is located beyond the DBD-coding sequence (Figure 3A and
Figure S2). The functional existence of a DHR3 isotype lacking
the DBD is supported by the chimeric EP/DHR3 transcripts. To
determine which DHR3 isotype was responsible for the genetic
interaction with dS6K, three UAS constructs were generated, two
of which corresponded to the RA and RB transcripts described
above. The third UAS construct, DHR3-RS, lacked an upstream
translational initiator codon, but retained an AUG, to potentially
allow translation of the PS variant (Figure 3A and Figure S2).
When induced by the ap-Gal4 driver, both RA and RB led to
lethality (data not shown). This lethality was most likely due to
expression in organs other than the wing, as the apterous promoter
is known to be active in several tissues, including some embryonic
neurons [46]. Conversely, induction of DHR3-RS with the ap-
Gal4 driver was not lethal and phenocopied the enhancement of
the dS6K wing phenotype observed with DHR3-R-EP (compare
Figure 3C and 3E with Figure 1B and 1E, respectively). Moreover,
co-induction of DHR3-RNAi suppressed this phenotype (compare
Figure 3E and 3G), as it did when co-expressed with dS6K and the
DHR3-R-EP (Figure 1K). Interestingly, induction of DHR3-RS
alone was sufficient to induce a bent-down wing (compare
Figure 3B and 3D), and this phenotype was largely reverted by
co-induction of DHR3-RNAi (data not shown). Hence, expression
of the DHR3 gene product lacking its DBD alone is sufficient to
induce growth of imaginal discs and can further cooperate with
dS6K in this process.
DHR3 regulates dS6K activity
The ability of ap-Gal4-driven DHR3-RS alone to induce the
bent-down wing phenotype (Figure 3D), as compared with DHR3-
EP (Figure 1D), could be explained by higher expression levels of
DHR3-PS (see below). Combined with data in Figure 1, these data
also suggest that DHR3-RS–driven growth relies on dS6K. To test
this possibility, we induced ap-Gal4-driven DHR3-RS in the dS6K
l-1
null-mutant, of which a small number survive to adulthood [18].
In this genetic background, a clear suppression of the bent-down
wing phenotype was observed (compare Figure 3F and 3D),
indicating that overgrowth induced by DHR3-RS is dependent on
the presence of dS6K. The genetic interactions between DHR3
and dS6K raised the possibility that DHR3 might control either
dS6K levels or activity. To discriminate between these two
possibilities, ubiquitous expression of DHR3-RNAi was induced
by a da-Gal4 or actin-Gal4 driver, and both the level and the
activity of dS6K were monitored in larval extracts. With either
driver, RNAi-induced DHR3 suppression led to a strong reduction
in dS6K activity, as measured by histone 2B (H2B) phosphory-
lation (Figure 3H) or dTORC1-dependent phosphorylation of
dS6K1 T398 [47](Figure S4). Under these conditions there was no
effect on dS6K protein levels (Figure 3H and Figure S4).
Figure 3. DHR3 regulates dS6K activity. (A) The DHR3 locus is
schematized at the top with the 2 EP insertions indicated (arrows). The
RA and RB transcripts encode a DBD sequence (indicated by the grey
box). RS is a putative novel transcript whose first AUG is located beyond
the DBD-coding sequences. (B–G) Adult wings in which the ap-Gal4
induces expression of the following UAS constructs: (B) ap-Gal4 control;
(C) UAS-dS6K; (D) UAS-DHR3-RS; (E) both UAS-dS6K and UAS-DHR3-RS;
(F) UAS-DHR3-RS in a dS6K
l-1 mutant escaper; (G) UAS-dS6K, UAS-DHR3-
RS, and UAS-DHR3-RNAi together. (H) Upper panel, H2B substrate
phosphorylation by dS6K from larval protein extracts. Ubiquitous
induction of UAS-DHR3 RNAi, using either a daughterless-Gal4 (da.Ri)
or an actin-Gal4 (ac.Ri) driver, provoked a drop in dS6K activity, as
compared with control drivers alone (da, ac). Middle and lower panels
are western blots detecting dS6K and a-tubulin, respectively.
doi:10.1371/journal.pgen.1000937.g003
DHR3 Regulates dS6K-Dependent Growth
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dTORC1-dependent phosphorylation of d4E-BP T37/T46
(Figure S4), the inhibitor of the translation initiation factor d4E
[48]. The results indicate that DHR3 is required during larval
development to maintain full dS6K activity, potentially acting
through dTORC1.
A DBD–lacking DHR3 protein
To determine whether the endogenous isoform DHR3-PS,
lacking the DBD, is expressed in vivo, a rabbit antiserum to DHR3
was produced using peptides that correspond to sequences
downstream of the first AUG following the DBD coding sequence
(Figure S2). Expression of the UAS–DHR3-RS (Figure 3A), was
induced in the posterior wing-disc compartment using the
engrailed-Gal4 (en-Gal4) driver. This line also harbored a UAS-
GFP, activated by the en-Gal4 driver leading to the production of
GFP, which allowed for double immunostaining. The results of
this experiment revealed co-localization of GFP and DHR3-PS
expressions (Figure 4A and 4B). Likewise, when induced by the ap-
Gal4 driver, both the DHR3-RS and the DHR3-EP lines
exhibited increased immunostaining within the dorsal wing-disc
compartment, which was much stronger for DHR3-RS than for
DHR3-EP (compare Figure 4C and 4D). Because DHR3-RS, but
not DHR3-EP, provoked the bent-down wing phenotype when
induced alone by ap-Gal4 (compare Figure 1D with Figure 3D),
these results are consistent with the ability of DHR3-RS to induce
growth in a dosage-dependent manner. To determine whether we
could also detect endogenous DHR3, flip-out clones directing
DHR3-RNAi expression were generated, and a UAS-GFP was
used to positively label these clones [49]. The staining observed in
prepupal discs was strongly reduced in flip-out clones (Figure 4E
and 4F), with remnant staining most likely reflecting incomplete
depletion of DHR3 expression. Clones displaying a decrease in
specific staining could be detected in all imaginal discs from
prepupae (data not shown), indicating that DHR3 is widely
represented at this stage of development. In addition, weak
staining could be detected in both the imaginal discs and the fat
body from mid-third-instar larvae (data not shown), suggesting the
presence of low levels of DHR3 at this stage. Thus, endogenous
DHR3 is detectable in prepupae, but also likely present at low
levels in larval tissues.
To analyze the distinct DHR3 polypeptides by western blotting,
expression of the UAS–cDNAs, DHR3-RA, RB, RS, or R-EP
(Figure 3A), were induced by a one-hour heat-shock treatment
using the heat-shock-Gal4 driver (HS-Gal4). Because larvae
expressing the DBD-containing DHR3 isotypes died within a
day following heat shock, larval extracts were prepared four hours
after heat shock and analyzed by western blotting. Larvae
expressing the DBD-containing DHR3 variants (RA and RB)
displayed distinct protein patterns. DHR3-RA produced a single
protein that migrated at the expected molecular weight for PA
(Figure 4G, lane RA). Similarly, DHR3-RB produced a band
migrating at a molecular weight very similar to that of PA, which
most likely represented PB (Figure 4G, lane RB). Unexpectedly,
DHR3-RB also produced a second polypeptide migrating at a
significantly smaller molecular weight (Figure 4G lane RB).
Consistent with this latter polypeptide representing the DHR3
variant lacking the DBD, the DHR3-RS and the two DHR3-EP
lines (Figure 4G, lanes RS, E1, and E2) produced a protein that
migrated at the same position as the smaller polypeptide produced
by DHR3-RB (Figure 4G, lane RB). According to the immuno-
staining (Figure 4C and 4D), the DHR3-RS line expressed
significantly more protein than the two DHR3-EP lines (compare
Figure 4G, lanes RS, E1, and E2). As DHR3 has been reported to
be highly expressed at the onset of metamorphosis in response to
ecdysone signaling [50], we monitored its expression pattern by
western blot analysis in third-instar larvae and during pupariation.
Neither the long nor the short forms of DHR3 could be observed
in late third-instar larvae, but both were clearly detectable in
prepupae (Figure 4H). That these two bands represent DHR3 was
shown by their reduced expression levels in prepupae expressing
the DHR3-RNAi using a da-Gal4 driver (Figure 4H). The smaller
protein was most likely produced from the DHR3-RB transcript
or, alternatively, from the RS messenger species devoid of an
upstream AUG (Figure 3A). These data are consistent with the
surge of DHR3 expression during pupariation.
Figure 4. Immunodetection of DHR3 proteins. (A–F) Wing imaginal discs stained with: (A, C, D, F) antibody to DHR3, and (B, E) antibody to GFP.
(A, B) Overexpression of DHR3-RS and USA-GFP in the posterior compartment was induced using an engrailed-Gal4 driver. (C) and (D) ap-Gal4 drives
overexpression of DHR3-RS and DHR3-EP, respectively. (E, F) Flip-out clone (induced 3 days prior to dissection) in a prepupal wing imaginal disc
expressing UAS-DHR3-RNAi and UAS-GFP. (E) Decrease in DHR3 staining in a flip-out clone labeled by GFP (F), indicating that DHR3 is expressed in
this tissue. (G) Western blot analysis of DHR3 in larval protein extracts from control (Co) and heat shock-induced UAS lines expressing DHR3-RA (RA),
DHR3-RB (RB), and DHR3-RS (RS) transcripts, or the DHR3-EPs (E1 and E2). (H) Western blot of the endogenous DHR3 protein in late third-instar larvae
(L3), prepupae (pp), and prepupae expressing an RNAi to DHR3 (RNAipp). In (G, H), the arrows at the left indicate the position of the DBD-containing
(high) and DBD-lacking (low) DHR3 proteins.
doi:10.1371/journal.pgen.1000937.g004
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autonomous growth
To gain further insight into the protein domain of DHR3
required for the dS6K-dependent growth function, an EMS
revertant screen was performed. DHR3-EP males were fed EMS
and crossed to females bearing ap-Gal4–induced dS6K. Approxi-
mately 50,000 offspring were screened to establish 8 lines that had
clearly lost the ability to cooperate with dS6K in producing the
bent-down wing phenotype (compare Figure 5A and 5B). After
remobilization of the EP-element, only two lines displayed
homozygous lethality and did not complement previously described
DHR3 mutants (Table S2). These two lines contained stop codons
at positions 243 and 284 of the DHR3-PA reading frame,
respectively, and are referred to as DHR3
K243X and DHR3
W284X
(Figure 5C and Figure S2). Remobilization of the EP element may
provoke imprecise excisions, creating putative deficiencies within
the DHR3 locus. Hence, several lines for each DHR3 mutation
were generated from independent remobilization events. Eight and
ten independent lines for DHR3
K243X and DHR3
W284X, respectively,
were used to further investigate the function of the DHR3 LBD. All
were homozygous lethal, failed to complement one another, and
neither complemented the previously described DHR3
G60S and
DHR3
R107G mutants [51] that affect the DBD (Table S2). Almost all
of these mutant combinations died as embryos indicating that the
LBD is required for the transcriptional function of DHR3.
However, it was possible to identify a few DHR3
K243X/DHR3
W284X
mutants that survived to the second larval instar. These larvae were
then used to perform kinase assays for dS6K. Consistent with the
results of assays using DHR3-RNAi extracts (Figure 3H), a
significant drop in dS6K activity, but not expression, was observed
in larval extracts prepared from trans-heterozygous DHR3
K243X/
DHR3
W284X mutants (Figure 5D and 5E).
To examine the LBD mutants with respect to cell-autonomous
growth, both lines devoid of the EP-element were fused to an
FRT, and using the flipase recombinase, analyzed in specific
tissues of the adult [52]. We first investigated the FRT-associated
mutations in the eye disc of heterozygous DHR3 mutant flies by
using the eyeless promoter to drive flipase during eye development
[53]. As the FRT chromosome arm carrying a wild-type DHR3
copy also contained a homozygous cell-lethal Minute mutation
(M(2)53), the recombined sister cells, which were wild type for
DHR3, were eliminated during development. This led to adult
eyes that were largely made up of homozygous DHR3 mutant
cells. With either the DHR3
K243X or DHR3
W284X mutation, a
significant reduction in eye size was observed (Figure 5F and 5G,
and data not shown), demonstrating that DHR3 controls growth
in a compartment-autonomous manner. The flipase recombinase
was also induced by heat shock, and adult homozygous DHR3
mutant clones were followed by their yellow marker. At the
scutellum (posterior part of the dorsal thorax), DHR3 mutant
yellow bristles were easily distinguishable from their neighbors and
were significantly reduced in size (Figure 5H). Thus, mutations in
the DHR3 ligand-binding domain appear to have significant
effects on growth, independent of differentiation.
To evaluate the growth defects due to DHR3 LBD mutation,
statistical analyses were performed on the size of eyes and
ommatidia as well as bristle length. Homozygous DHR3-mutant
eyes were generated in a trans-heterozygous M(2)53/DHR3
2
mutant background, which produces variation in the body size of
adult flies (data not shown). Therefore, the areas of the
homozygous eyes were normalized to the areas of the correspond-
ing heterozygous thoraces. As compared to control recombined
eyes, the homozygous DHR3
K243X and DHR3
W284X mutant eyes
exhibited a significant reduction in surface area (Figure 6A). The
surface area of ommatidia from scanning electron micrographs of
flies of equivalent size was also determined. Notably, the reduction
in ommatidia area (Figure 6B) was not as strong as for the surface
of the entire eye, indicating that the number of ommatidia was also
Figure 5. Mutations in the LBD of DHR3. (A, B) The ap-Gal4 driver induces dS6K in combination with either (A) the DHR3-EP transgene or (B) the
EP with the EMS DHR3 mutation. (C) Structure of the full-length DHR3-PA protein showing previously described DBD mutants (G60S, R107G) and the
EMS mutants that lack the LBD (K243X, W284X); the light and dark grey boxes represent the DBD and the LBD respectively. (D) dS6K activity in larval
protein extracts measured by H2B target phosphorylation and (E) corresponding western blot of dS6K in the trans-heterozygote LBD-mutant
combination (LBD), as compared to heterozygous larvae (Co). (F, G) The eyeless promoter directs the flipase recombinase during eye development.
Flipase allows recombination on the right arm of the second chromosome and eventually leads to an adult eye (F) that is homozygous for the wild-
type allele of DHR3. (G) Homozygosity for a DHR3
K243X mutation results in a decrease in the size of the adult eye. A dotted yellow line surrounding the
control eye in (F) has been copied and pasted on the mutant eyes (G); insets are higher magnification images of ommatidia showing misorientation
of bristles. (H) At the scutellum, a y-marked homozygous DHR3
K243X mutant bristle (arrow), recognizable by its light color, is smaller than the
symmetrical neighboring bristles.
doi:10.1371/journal.pgen.1000937.g005
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length was analyzed at the edge of the wing margin, as the shaft of
each bristle corresponds to a single cell. Comparison of homo-
zygous clonal bristles to the neighboring control bristles
(Figure 6C–6E) revealed that the length of homozygous yellow-
marked bristles was unaffected (Figure 6C and 6F), indicating that,
in this setting, the yellow marker is appropriate to monitor cell-
autonomous growth. In contrast, there was a significant reduction
in the size of both DHR3
K243X and DHR3
W284X homozygous
mutant bristles, as compared to the neighboring control bristles
(Figure 6D–6F) indicating that the LBD of DHR3 is required to
sustain cell-autonomous growth. The DHR3 homozygous mutant
bristles were affected also in their orientation, as compared with
the surrounding bristles (Figure 6D and 6E). Misorientation was
also observed for the ommatidia-associated bristles in homozygous
DHR3-LBD mutant eyes (insets in Figure 5F and 5G), potentially
reflecting one of the pleiotropic functions of DHR3. Taken
together, our findings demonstrate that, in addition to a role in
coordinating the onset of metamorphosis, DHR3 also acts in a
cell-autonomous manner to control cell growth.
Discussion
By using Drosophila genetics and a gain-of-function strategy, we
identified the NR, DHR3, as an enhancer of a dS6K-regulated
growth phenotype. This effect can be mediated by an isoform of
DHR3 lacking the DBD. Moreover, using a revertant screening
strategy, we have generated LBD-specific DHR3 mutants and
demonstrated that the LBD of DHR3 is necessary to maintain
normal growth and dS6K activity. In contrast to the role DHR3
plays in transcriptional regulation affecting the onset of metamor-
phosis [41,42], our studies indicate that it also plays a role in
regulating cell-autonomous growth. These effects are most likely
mediated through dS6K, as the ability of ectopically expressed
DHR3-RS to drive growth in the dorsal wing blade is blunted in
Drosophila deficient for dS6K. Consistent with these findings, we
have previously demonstrated that dS6K also controls cell growth
in a cell-autonomous manner [18]. However, the effect on cell size
is more pronounced in dS6K mutants [18] than in the DHR3-
mutant clones described here. This may reflect the fact that dS6K
activity is blunted, but not abolished, in DHR3 LBD-mutant
larvae. Compatible with this hypothesis, we previously found that
in a dS6K P-element–induced mutant (P{PZ}S6K[07084]) we
could not detect dS6K protein (unpublished results); however, this
mutation induced a much less severe phenotype as compared with
the dS6K
l-1 null mutation [18]. In homozygous DHR3 mutant eyes
both the size and the number of ommatidia were decreased,
whereas in dS6K mutant flies the size reduction of the eye was
only due to a decrease in ommatidia size but not number [18].
This difference might be attributed to the experimental settings. In
the current study, DHR3 mutant eyes were generated by mitotic
recombination in a heterozygous Minute background, whose
developmental delay is less than two days. In contrast, the size
and number of ommatidia in dS6K mutant eyes were measured in
homozygous mutant flies that exhibit a five-day delay at eclosion.
The longer time for the latter to emerge as adults allows additional
cell divisions to proceed, leading to a higher number of ommatidia
[54].
Previous studies demonstrated that DHR3 participates in a
hierarchal regulatory circuit in response to ecdysone signaling
[41,55], but also acts in a negative feedback loop to repress
ecdysone receptor-mediated signaling [42]. Prothoracic gland
production of ecdysone is mediated by the brain neuropeptide
prothoracicotropic hormone (PTTH) [56]. Recent studies in
Drosophila have shown that genetic ablation of PTTH-producing
neurons induces a delay in larval development and results in larger
adult flies as a direct consequence of reduced levels of ecdysone
[29]. Interestingly, in the tobacco hornworm, Manduca sexta,
PTTH-induced ecdysone production is paralleled by the phos-
phorylation of the Manduca orthologue of Drosophila ribosomal
protein S6 [28]. Moreover, this process is sensitive to rapamycin
[28] and we have observed a burst of dS6K activity at early
pupation (unpublished data). As the body size of the adult fly
appears to be determined by growth regulators, including dS6K,
as well as by hormones that control the timing of developmental
windows, such as PTTH, our results suggest that the DHR3/
dS6K regulatory module acts to integrate these two processes.
The studies presented here support the existence of a novel
DHR3 polypeptide devoid of a DBD, DHR3-PS. Nonetheless,
Figure 6. Growth defect in DHR3 LBD mutant cells. (A) Normalized eye size (mm
2) of control (black bar; n=20), DHR3
W284X (grey bar; n=18) and
DHR3
K243X (white bar; n=18) mutants. As compared to control recombined eyes (Co), DHR3
W284X and DHR3
K243X mutant eyes exhibit a highly
significant size reduction (***P,0.001). (B) Ommatidia size of control (black bar), DHR3
W284X (grey bar), and DHR3
K243X (white bar) mutants. As
compared to control recombined eyes (Co), DHR3
W284X and DHR3
K243X mutant ommatidia exhibit a significant size reduction (**P,0.01). (C–E)
Comparison of y-marked homozygous clonal bristles (black arrows) to their neighboring heterozygous bristles (white arrows) at the wing margin.
Note that control clonal bristles are of normal size and orientation (C), whereas those of DHR3
W284X (D) and DHR3
K243X (E) are reduced in size and are
misoriented. (F) Size measurements (mm) of the length of homozygous clones (y2) and their neighboring heterozygous (y+) bristles (n=51 for each
bar). The size reduction of clonal versus neighbor bristles is highly significant for DHR3
K243X (***P,0.001) and DHR3
W284X (***P,0.001) mutants, but
not for the control (Co) bristles (P=0.028).
doi:10.1371/journal.pgen.1000937.g006
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growth phenotype, we can not exclude that the other DBD-
containing DHR3 isoforms also contribute to dS6K activation. In
general, DHR3, like other NRs, is a transcription factor composed
of four elements: a modulator domain, the DBD, the hinge region,
and the LBD [57]. The DBD of NRs typically consists of two zinc
fingers, with the first being critical for conferring DNA-binding
specificity [58]. Like DHR3-PS, NRs lacking a DBD have been
previously reported. Notably, in Drosophila, the NR E75B, a DHR3
partner, lacks one of the 2 zinc fingers that is required to form a
functional DBD [59]. However, E75B, through its ability to
interact with DHR3, modulates DHR3 transcriptional activity in a
gas-responsive manner [60]. Like the putative DHR3-PS, the NR
short heterodimer partner (SHP) in mammals is also devoid of
DBD, but, as with E75B, it interacts with other NRs to modulate
their transcriptional activity [61]. It is unlikely that DHR3-PS
behaves as a dominant-interfering effector of full-length DHR3 as
ectopic DHR3-PS expression induces growth, whereas DHR3-
RNAi inhibits growth. However, DHR3 also heterodimerizes with
two NRs: E75 and the ecdysone receptor [41,42]. Thus, in the
case of E75, ectopically expressed DHR3-PS may act to decrease
the levels of free E75, leaving full-length DHR3 free to increase the
transcription of target genes. In contrast, DHR3-PS binding to the
ecdysone receptor could counteract the negative growth regulation
mediated by ecdysone signaling [31]. However, it should be noted
that the negative effects of ecdysone are humoral [33] and
mediated by dFOXO-inactivation within the fat body [31],
whereas, as we have shown here, DHR3 regulates growth in a
cell-autonomous manner. Moreover, dFOXO subcellular distri-
bution was not altered in DHR3 mutant clones in third instar wing
imaginal discs (data not shown), indicating that the DHR3 cell-
autonomous effect on cell growth is not mediated by the PKB/
dFOXO signaling.
In contrast to acting as a dominant-interfering isoform, the
results presented here also suggest that DHR3 activates dS6K
through a non-genomic mechanism, an effect of NRs that does not
require the DBD function. Such a model is supported by NR
responses whose kinetics are too rapid to be explained by de novo
transcription and translation of a gene product [62]. Indeed,
nongenomic effects typically occur within minutes following
addition of the cognate ligand and are resistant to transcriptional
inhibitors. In the case of DHR3, it is experimentally difficult to
address this question as the ligand for DHR3 is unknown and we
are scoring for a genetic endpoint resulting from events induced
much earlier in larval development. It has been demonstrated that
vitamin D3 [63,64] and all-trans-retinoic acid [65] both induce
activation of S6K1 within minutes of administration to cells.
Moreover, in the case of vitamin D3, it was shown that these
effects were mediated through protein phosphatases PP1 and
PP2A in a vitamin D3 receptor (VDR)-dependent manner. VDR
appears to directly interact with the catalytic subunits of PPI and
PP2A, and vitamin D3 acts to disrupt this interaction and enhance
an interaction between VDR and S6K1, stabilizing S6K1 in its
phosphorylated active state [63,64]. However, depleting DHR3
levels by RNA interference blunts both dS6K T398 and d4E-BP
T37/T46 phosphorylation, suggesting that DHR3 acts upstream
or at the level of dTORC1. Identification of potential partners for
DHR3-PS may be useful in determining, at the molecular level,
the mechanism by which DHR3 controls cell growth and dS6K
activity.
The data further support the notion that a ligand exists for
DHR3, and that the ligand is required for many of the pleiotropic
activities of DHR3. Those NRs that bind steroid hormones are, in
general, high-affinity receptors, whereas the low-affinity NRs bind
ligands that are present in high concentration, such as dietary
nutrients [66]. The observation that an NR, generated by fusing
the DHR3 LBD with the DBD of Gal4, is transcriptionally active
in a number of specific embryonic and larval tissues suggests that
such a ligand is widely present [67]. Given the role of dTOR/
dS6K as a nutritional effector [14], it is interesting to note that the
chimeric DHR3/Gal4 NR is active in organs that provide basal
nutrients, in particular, in a group of cells of the larval midgut,
which are essential for the transfer of nutrients to the hemolymph
[67]. Importantly, the mammalian orthologues to DHR3 and its
partner E75 are retinoid-related orphan receptor (ROR)a and
Rev-erb (NR1D)a, respectively [68]. As in Drosophila, the NR1D
subgroup functions as dominant transcriptional silencers by
inhibiting transactivation mediated by RORa [68]. Interestingly,
it was recently reported that RORa-deficient mice, like S6K1-
deficient mice [69], exhibit reduced fat-pad mass, smaller
adipocytes, and resistance to diet-induced obesity [70]. Moreover,
in solving the X-ray structure of the RORa LBD, it was revealed
that cholesterol was bound in the ligand-binding pocket [71].
While the Drosophila NR, DHR96, has recently been shown to bind
cholesterol thereby modulating cholesterol homeostasis [72], this
does not exclude the possibility that DHR3 could also bind
cholesterol. However, the predicted models of the structure of
DHR3 indicate that the size of the ligand-binding pocket is smaller
than those of either RORa or RORb [73]. Given the role of the
mTOR/S6K1 nutrient-responsive pathway in mammals [74], it
raises the possibility that DHR3 is a low-affinity receptor for an
abundant nutrient ligand. Identification of this specific ligand
constitutes the next issue to investigate.
Materials and Methods
Fly stocks and genetics
The following fly strains were used: dS6K
l1 and UAS-dS6K; ap-
Gal4 [18]; UAS-Tsc1/2 [7]; UAS-PTEN [75]; pumpless-Gal4
[14]; DHR3
G60S and DHR3
R107G [51]; eyeless-Gal4 [76]; Cre-lox
(a generous gift from K. Basler); actin5c.CD2.Gal4,UAS-GFP
[77]; and da-Gal4, actin-Gal4, engrailed-Gal4,UAS-GFP, FRT-
42D,M(2)53, and FRT-42D,P(y+)44B (Bloomington stock center).
Because y+ and w+ markers were used, all the experiments were
performed in a y,w genetic background. In the screen, lines with
about 5000 independent EPy+ insertions [39] were mated to ap-
Gal4.UAS-dS6K virgin females and offspring were scored for
modulation of the bent-down wing phenotype. Approximately 900
suppressor and 100 enhancer lines were further analyzed for their
effects on wing development when mated to ap-Gal4 virgin
females. In a third step, 90 enhancer and 130 suppressor lines were
retained and mated to either ap-Gal4.UAS-dS6K or ap-
Gal4.UAS-S6K1
dE/D3E virgin females, to test their differential
effect on dS6K versus S6K1
dE/D3E. For the EMS revertant screen,
about 500 DHR3-R-EP males were starved overnight and then
transferred on wet paper containing a 25 mM EMS solution in
10 mg/ml sucrose. After one day, these males were mated to
approximately 1500 ap-Gal4.UAS-dS6K virgin females. Flies
were then transferred every day for egg laying. An estimated
150,000 F1 flies were obtained; as both parental lines were
balanced over a CyO chromosome, about 50,000 flies were
screened for the reversion of the bent-down-wing phenotype.
Mapping and cDNA constructs
Localization of the EP insertions was performed as described
[39]. To generate UAS-DHR3-RNAi, a PCR fragment spanning
the DHR3 reading frame from Leu
114 to Lys
265 was cloned as
described [78]. Congruent results were obtained by repeating the
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provided by H. Tricoire and the National Institute of Genetics
(http://www.nig.ac.jp/). For RACE-PCR, polyA+ cDNAs were
obtained by using the RNeasy kit and Oligotex mRNA
purification (both from Qiagen) and then amplified with the
SMART RACE cDNA Amplification Kit (Clontech). 59 RACE to
obtain endogenous cDNAs and the chimeric DHR3-EP cDNAs
followed a 2-step process: first, using a DHRS-RR–specific primer
(catggtctgctgtggcgtcacggaggc) and universal primer mix, and then
by nested PCR using a combination of nested universal primer
mix/DHRS-RR–specific primer (cggttgcgattaacacggtccaccac).
UAS-S6K1
dE/D3E and DHR3 cDNAs were cloned in the pUAST
vector and injected as previously described [18]. The RA-cDNA
was kindly provided by Carl Thummel; the RB- cDNA was
obtained from DGRC; the RS transcript was artificially generated
by truncation of the RA-cDNA lacking the AUG initiator codon
upstream of the DBD coding sequences. To identify EMS point
mutations, DHR3 coding sequences were PCR amplified from the
genomic DNA of revertant flies. Fragments were then sequenced
and searched for double picks, as compared with wild-type
genomic DNA. Identified point mutations were confirmed by
independent repetition of the entire procedure.
Tissue analyses
Larval tissues were dissected, stained as previously described
[18], and then observed on a Leica Sp2 confocal microscope. For
SEM, flies were fixed by successive baths of increasingly
concentrated ethanol solution, up to 90%, and directly observed
on an S-3000N HITACHI scanning-electron microscope. To
measure eye area, eye-flp;FRT-42D,M(2)53 females were mated to
FRT-42D,P(y+)44B control males, and to FRT-DHR3
K243X and
FRT-DHR3
W284X mutant males. Photographs of offspring female
flies were used to measure the area of homozygous eyes and
heterozygous thoraces, as described [18]. To circumvent potential
individual variation, the eye size of each individual was normalized
to its corresponding thorax. The ommatidia size was measured
from SEM pictures of 6 flies of identical size for each genotype.
Biochemical and immunohistochemical analyses
Protein extracts were prepared and western blotting was
performed as previously described [13]. To select prepupae,
wandering larvae of the corresponding phenotype were collected
and transferred to a new tube. After 8 hours, newly formed
prepupae and late third-instar larvae were collected to make
protein extracts. The in vitro dS6K kinase activity assays were
performed on second-instar larval extracts, essentially as described
[13] using histone H2B as the substrate [79]. The antiserum to
DHR3 was produced commercially by Eurogentec. The peptides
144QMRAQSDAAPDSSYYD
159 and
209SADYVDSTTYEPR-
STI
224 were used to immunize rabbits. The specific anti-peptide
antibodies were then affinity purified as previously described [80].
Supporting Information
Figure S1 EP-elements and dS6K interactions at the dorsal wing
compartment. The ap promoter directed Gal4 expression within
the dorsal compartment of the wing imaginal disc (A) to induce
UAS-dS6K (B–D) with various UAS constructs: (F) EP-12.190
induces a bending-up of the wing acting along the antero-posterior
axis; (G) EP-21.118 induces a bending-down of the wing following
the antero-posterior axis. Dorsal side is to the left and ventral is to
the right in each wing photograph.
Found at: doi:10.1371/journal.pgen.1000937.s001 (1.93 MB TIF)
Figure S2 DHR3 transcripts and polypeptides. (A) The
EP12.218 (E1) and EP23.014 (E2) are inserted into chromosome
2R at nucleotides 6107302 and 6107230 respectively. (B) 59end of
a chimeric mRNA produced upon EP induction by Gal4; EP
sequences are italicized. The following DHR3-specific primers
were used for the first step (catggtctgctgtggcgtcacggaggc) and for
the nested step (cggttgcgattaacacggtccaccac). (C) 59end of a novel
DHR3 transcript (DHR3-RS), starting at nucleotide 6097546 of
chromosome 2R. The nucleotide sequence corresponding to the
classically referenced DHR3 2nd exon is shown in normal
characters; the first initiator codon for each transcript is boxed.
(D) EMS point mutations (boxed letters) of the DHR3 polypeptide
PA; G60S (G) and R107G (R) affect the DBD, whereas K243X
(K) and W284X (W) are early stop codons within the LBD
(underlined). Methionines are shown in bold; the peptides
144QMRAQSDAAPDSSYYD159 and 209SADYVDSTTYEPR-
STI224, which were used for rabbit immunizations, are
highlighted.
Found at: doi:10.1371/journal.pgen.1000937.s002 (0.02 MB PDF)
Figure S3 Transheterozygous DHR3-EP have reduced prepu-
pal weight. Heterozygous control (Co) and transheterozygous
DHR3-EP (EP) wandering larvae were collected. Males and
females were transferred in separate tubes. Weights were then
determined on 20 prepupae formed after 8 hours for each sample.
As compared to control, transheterozygous DHR3-EP exhibit a
significant 8% reduction in body weight (**P,0.01).
Found at: doi:10.1371/journal.pgen.1000937.s003 (0.85 MB TIF)
Figure S4 DHR3 RNAi blunts DHR3 mRNA levels and the
phosphorylation of dS6K and d4E-BP. (A) Q-PCR from either
act-Gal4 (Co) or act-Gal.DHR3-RNAi (Ri) white prepupa. (B–E)
Western-blot analysis of Drosophila a-Tubulin levels (B), dS6K
levels (C), and the phosphorylation of dS6K T398 (D) and d4E-BP
T37/T46 (E) in either act-Gal4 (Co) or act-Gal.DHR3-RNAi
(Ri) third instar larval extracts.
Found at: doi:10.1371/journal.pgen.1000937.s004 (1.71 MB TIF)
Table S1 Screening for modulators of dS6K.
Found at: doi:10.1371/journal.pgen.1000937.s005 (0.10 MB PDF)
Table S2 Complementation tests between DHR3 mutants.
Found at: doi:10.1371/journal.pgen.1000937.s006 (0.03 MB PDF)
Acknowledgments
We wish to thank L. Carnevalli, A.-M. Pret, N. Randsholt, and A. Selvaraj
for critical reading of the manuscript; H. Tricoire, K. Basler, and the
National Institute of Genetics (Japan) for fly stocks; Carl Thummel for
DHR3 cDNA; P. Leopold for antibody to dFOXO; and F. Mery for
statistical analysis. We are also indebted to M. Daston for her critical
editing of the manuscript and G. Doerman for preparing the figures.
Author Contributions
Conceived and designed the experiments: JM HS EH GT. Performed the
experiments: JM CL JPP JMB TR MLR FZ NV. Analyzed the data: JM
JPP GT. Contributed reagents/materials/analysis tools: EH. Wrote the
paper: JM SCK GT.
References
1. Conlon I, Raff M (1999) Size control in animal development. Cell 96: 235–
244.
2. Dann SG, Selvaraj A, Thomas G (2007) mTOR Complex1-S6K1 signaling: at
the crossroads of obesity, diabetes and cancer. Trends Mol Med 13: 252–259.
DHR3 Regulates dS6K-Dependent Growth
PLoS Genetics | www.plosgenetics.org 10 May 2010 | Volume 6 | Issue 5 | e10009373. Edgar BA (2006) How flies get their size: genetics meets physiology. Nat Rev
Genet 7: 907–916.
4. Montagne J, Radimerski T, Thomas G (2001) Insulin signaling: lessons from the
Drosophila tuberous sclerosis complex, a tumor suppressor. Sci STKE 2001:
PE36.
5. Gao X, Pan D (2001) TSC1 and TSC2 tumor suppressors antagonize insulin
signaling in cell growth. Genes Dev 15: 1383–1392.
6. Potter CJ, Huang H, Xu T (2001) Drosophila Tsc1 functions with Tsc2 to
antagonize insulin signaling in regulating cell growth, cell proliferation, and
organ size. Cell 105: 357–368.
7. Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK (2001) The Drosophila
tuberous sclerosis complex gene homologs restrict cell growth and cell
proliferation. Cell 105: 345–355.
8. Saucedo LJ, Gao X, Chiarelli DA, Li L, Pan D, et al. (2003) Rheb promotes cell
growth as a component of the insulin/TOR signalling network. Nat Cell Biol 5:
566–571.
9. Stocker H, Radimerski T, Schindelholz B, Wittwer F, Belawat P, et al. (2003)
Rheb is an essential regulator of S6K in controlling cell growth in Drosophila.
Nat Cell Biol 5: 559–565.
10. Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, et al. (2003) Rheb is a direct
target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5:
578–581.
11. Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J (2005) Rheb binds and
regulates the mTOR kinase. Curr Biol 15: 702–713.
12. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R, et al. (2001) An
evolutionarily conserved function of the Drosophila insulin receptor and insulin-
like peptides in growth control. Curr Biol 11: 213–221.
13. Oldham S, Montagne J, Radimerski T, Thomas G, Hafen E (2000) Genetic and
biochemical characterization of dTOR, the Drosophila homolog of the target of
rapamycin. Genes Dev 14: 2689–2694.
14. Colombani J, Raisin S, Pantalacci S, Radimerski T, Montagne J, et al. (2003) A
nutrient sensor mechanism controls Drosophila growth. Cell 114: 739–749.
15. Radimerski T, Montagne J, Hemmings-Mieszczak M, Thomas G (2002)
Lethality of Drosophila lacking TSC tumor suppressor function rescued by
reducing dS6K signaling. Genes Dev 16: 2627–2632.
16. Long X, Ortiz-Vega S, Lin Y, Avruch J (2005) Rheb binding to mammalian
target of rapamycin (mTOR) is regulated by amino acid sufficiency. J Biol Chem
280: 23433–23436.
17. Radimerski T, Montagne J, Rintelen F, Stocker H, van der Kaay J, et al. (2002)
dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires
dPDK1. Nat Cell Biol 4: 251–255.
18. Montagne J, Stewart MJ, Stocker H, Hafen E, Kozma SC, et al. (1999)
Drosophila S6 kinase: a regulator of cell size. Science 285: 2126–2129.
19. Barcelo H, Stewart MJ (2002) Altering Drosophila S6 kinase activity is consistent
with a role for S6 kinase in growth. Genesis 34: 83–85.
20. Pende M, Kozma SC, Jaquet M, Oorschot V, Burcelin R, et al. (2000)
Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-
deficient mice. Nature 408: 994–997.
21. Britton JS, Edgar BA (1998) Environmental control of the cell cycle in
Drosophila: nutrition activates mitotic and endoreplicative cells by distinct
mechanisms. Development 125: 2149–2158.
22. Garcia-Bellido A, Ripoll P, Morata G (1976) Developmental compartmental-
ization in the dorsal mesothoracic disc of Drosophila. Dev Biol 48: 132–147.
23. Slaidina M, Delanoue R, Gronke S, Partridge L, Leopold P (2009) A Drosophila
insulin-like peptide promotes growth during nonfeeding states. Dev Cell 17:
874–884.
24. Riddiford LM, Cherbas P, Truman JW (2000) Ecdysone receptors and their
biological actions. Vitam Horm 60: 1–73.
25. Lee CY, Baehrecke EH (2001) Steroid regulation of autophagic programmed
cell death during development. Development 128: 1443–1455.
26. Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular
degradation. Science 290: 1717–1721.
27. Scott RC, Schuldiner O, Neufeld TP (2004) Role and regulation of starvation-
induced autophagy in the Drosophila fat body. Dev Cell 7: 167–178.
28. Song Q, Gilbert LI (1995) Multiple phosphorylation of ribosomal protein S6 and
specific protein synthesis are required for prothoracicotropic hormone-
stimulated ecdysteroid biosynthesis in the prothoracic glands of Manduca sexta.
Insect Biochem Mol Biol 25: 591–602.
29. McBrayer Z, Ono H, Shimell M, Parvy JP, Beckstead RB, et al. (2007)
Prothoracicotropic hormone regulates developmental timing and body size in
Drosophila. Dev Cell 13: 857–871.
30. Caldwell PE, Walkiewicz M, Stern M (2005) Ras activity in the Drosophila
prothoracic gland regulates body size and developmental rate via ecdysone
release. Curr Biol 15: 1785–1795.
31. Colombani J, Bianchini L, Layalle S, Pondeville E, Dauphin-Villemant C, et al.
(2005) Antagonistic actions of ecdysone and insulins determine final size in
Drosophila. Science 310: 667–670.
32. Mirth C (2005) Ecdysteroid control of metamorphosis in the differentiating adult
leg structures of Drosophila melanogaster. Dev Biol 278: 163–174.
33. Layalle S, Arquier N, Leopold P (2008) The TOR pathway couples nutrition
and developmental timing in Drosophila. Dev Cell 15: 568–577.
34. Okamoto N, Yamanaka N, Yagi Y, Nishida Y, Kataoka H, et al. (2009) A fat
body-derived IGF-like peptide regulates postfeeding growth in Drosophila. Dev
Cell 17: 885–891.
35. Alessi DR, Kozlowski MT, Weng QP, Morrice N, Avruch J (1998) 3-
Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and
activates the p70 S6 kinase in vivo and in vitro. Curr Biol 8: 69–81.
36. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, et al. (1998)
Phosphorylation and activation of p70s6k by PDK1. Science 279: 707–710.
37. Dennis PB, Pullen N, Kozma SC, Thomas G (1996) The principal rapamycin-
sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially
regulated by rapamycin-insensitive kinase kinases. Mol Cell Biol 16: 6242–6251.
38. Rintelen F, Stocker H, Thomas G, Hafen E (2001) PDK1 regulates growth
through Akt and S6K in Drosophila. Proc Natl Acad Sci U S A 98:
15020–15025.
39. Reiling JH, Hafen E (2004) The hypoxia-induced paralogs Scylla and Charybdis
inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila.
Genes Dev 18: 2879–2892.
40. Nobukuni T, Kozma SC, Thomas G (2007) hvps34, an ancient player, enters a
growing game: mTOR Complex1/S6K1 signaling. Curr Opin Cell Biol 19:
135–141.
41. Lam GT, Jiang C, Thummel CS (1997) Coordination of larval and prepupal
gene expression by the DHR3 orphan receptor during Drosophila metamor-
phosis. Development 124: 1757–1769.
42. White KP, Hurban P, Watanabe T, Hogness DS (1997) Coordination of
Drosophila metamorphosis by two ecdysone-induced nuclear receptors. Science
276: 114–117.
43. Bohni R, Riesgo-Escovar J, Oldham S, Brogiolo W, Stocker H, et al. (1999)
Autonomous control of cell and organ size by CHICO, a Drosophila homolog of
vertebrate IRS1-4. Cell 97: 865–875.
44. King-Jones K, Thummel CS (2005) Nuclear receptors–a perspective from
Drosophila. Nat Rev Genet 6: 311–323.
45. Wilson RJ, Goodman JL, Strelets VB (2008) FlyBase: integration and
improvements to query tools. Nucleic Acids Res 36: D588–593.
46. Herzig MC, Thor S, Thomas JB, Reichert H, Hirth F (2001) Expression and
function of the LIM homeodomain protein Apterous during embryonic brain
development of Drosophila. Dev Genes Evol 211: 545–554.
47. Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, et al. (2002) Two
TOR complexes, only one of which is rapamycin sensitive, have distinct roles in
cell growth control. Mol Cell 10: 457–468.
48. Miron M, Verdu J, Lachance PE, Birnbaum MJ, Lasko PF, et al. (2001) The
translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell
growth in Drosophila. Nat Cell Biol 3: 596–601.
49. Neufeld TP, de la Cruz AF, Johnston LA, Edgar BA (1998) Coordination of
growth and cell division in the Drosophila wing. Cell 93: 1183–1193.
50. Koelle MR, Segraves WA, Hogness DS (1992) DHR3: a Drosophila steroid
receptor homolog. Proc Natl Acad Sci U S A 89: 6167–6171.
51. Carney GE, Wade AA, Sapra R, Goldstein ES, Bender M (1997) DHR3, an
ecdysone-inducible early-late gene encoding a Drosophila nuclear receptor, is
required for embryogenesis. Proc Natl Acad Sci U S A 94: 12024–12029.
52. Xu T, Rubin GM (1993) Analysis of genetic mosaics in developing and adult
Drosophila tissues. Development 117: 1223–1237.
53. Newsome TP, Asling B, Dickson BJ (2000) Analysis of Drosophila photoreceptor
axon guidance in eye-specific mosaics. Development 127: 851–860.
54. Montagne J (2000) Genetic and molecular mechanisms of cell size control. Mol
Cell Biol Res Commun 4: 195–202.
55. Sullivan AA, Thummel CS (2003) Temporal profiles of nuclear receptor gene
expression reveal coordinate transcriptional responses during Drosophila
development. Mol Endocrinol 17: 2125–2137.
56. Huang X, Warren JT, Gilbert LI (2008) New players in the regulation of
ecdysone biosynthesis. J Genet Genomics 35: 1–10.
57. McKenna NJ, O’Malley BW (2002) Combinatorial control of gene expression by
nuclear receptors and coregulators. Cell 108: 465–474.
58. Umesono K, Evans RM (1989) Determinants of target gene specificity for
steroid/thyroid hormone receptors. Cell 57: 1139–1146.
59. Bialecki M, Shilton A, Fichtenberg C, Segraves WA, Thummel CS (2002) Loss
of the ecdysteroid-inducible E75A orphan nuclear receptor uncouples molting
from metamorphosis in Drosophila. Dev Cell 3: 209–220.
60. Reinking J, Lam MM, Pardee K, Sampson HM, Liu S, et al. (2005) The
Drosophila nuclear receptor e75 contains heme and is gas responsive. Cell 122:
195–207.
61. Seol W, Choi HS, Moore DD (1996) An orphan nuclear hormone receptor that
lacks a DNA binding domain and heterodimerizes with other receptors. Science
272: 1336–1339.
62. Losel R, Wehling M (2003) Nongenomic actions of steroid hormones. Nat Rev
Mol Cell Biol 4: 46–56.
63. Bettoun DJ, Buck DW, 2nd, Lu J, Khalifa B, Chin WW, et al. (2002) A vitamin
D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its
enzymatic activities by the ligand. J Biol Chem 277: 24847–24850.
64. Bettoun DJ, Lu J, Khalifa B, Yee Y, Chin WW, et al. (2004) Ligand modulates
VDR-Ser/Thr protein phosphatase interaction and p70S6 kinase phosphory-
lation in a cell-context-dependent manner. J Steroid Biochem Mol Biol 89–90:
195–198.
65. Lal L, Li Y, Smith J, Sassano A, Uddin S, et al. (2005) Activation of the p70 S6
kinase by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood
105: 1669–1677.
66. Berkenstam A, Gustafsson JA (2005) Nuclear receptors and their relevance to
diseases related to lipid metabolism. Curr Opin Pharmacol 5: 171–176.
DHR3 Regulates dS6K-Dependent Growth
PLoS Genetics | www.plosgenetics.org 11 May 2010 | Volume 6 | Issue 5 | e100093767. Palanker L, Necakov AS, Sampson HM, Ni R, Hu C, et al. (2006) Dynamic
regulation of Drosophila nuclear receptor activity in vivo. Development 133:
3549–3562.
68. Ramakrishnan SN, Muscat GE (2006) The orphan Rev-erb nuclear receptors: a
link between metabolism, circadian rhythm and inflammation? Nucl Recept
Signal 4: e009.
69. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, et al. (2004) Absence of
S6K1 protects against age- and diet-induced obesity while enhancing insulin
sensitivity. Nature 431: 200–205.
70. Lau P, Fitzsimmons R, Raichur S, Wang SC, Lechtken A, et al. (2008) The
orphan nuclear receptor, RORalpha , regulates gene expression that controls
lipid metabolism: staggerer (sg/sg) mice are resistant to diet induced obesity.
J Biol Chem.
71. Kallen JA, Schlaeppi JM, Bitsch F, Geisse S, Geiser M, et al. (2002) X-ray
structure of the hRORalpha LBD at 1.63 A: structural and functional data that
cholesterol or a cholesterol derivative is the natural ligand of RORalpha.
Structure 10: 1697–1707.
72. Horner MA, Pardee K, Liu S, King-Jones K, Lajoie G, et al. (2009) The
Drosophila DHR96 nuclear receptor binds cholesterol and regulates cholesterol
homeostasis. Genes Dev 23: 2711–2716.
73. Stehlin C, Wurtz JM, Steinmetz A, Greiner E, Schule R, et al. (2001) X-ray
structure of the orphan nuclear receptor RORbeta ligand-binding domain in the
active conformation. Embo J 20: 5822–5831.
74. Um SH, D’Alessio D, Thomas G (2006) Nutrient overload, insulin resistance,
and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3: 393–402.
75. Huang H, Potter CJ, Tao W, Li DM, Brogiolo W, et al. (1999) PTEN affects cell
size, cell proliferation and apoptosis during Drosophila eye development.
Development 126: 5365–5372.
76. Hauck B, Gehring WJ, Walldorf U (1999) Functional analysis of an eye specific
enhancer of the eyeless gene in Drosophila. Proc Natl Acad Sci U S A 96:
564–569.
77. Neufeld TP (2003) Shrinkage control: regulation of insulin-mediated growth by
FOXO transcription factors. J Biol 2: 18.
78. Reichhart JM, Ligoxygakis P, Naitza S, Woerfel G, Imler JL, et al. (2002) Splice-
activated UAS hairpin vector gives complete RNAi knockout of single or double
target transcripts in Drosophila melanogaster. Genesis 34: 160–164.
79. Reiling JH, Doepfner KT, Hafen E, Stocker H (2005) Diet-dependent effects of
the Drosophila Mnk1/Mnk2 homolog Lk6 on growth via eIF4E. Curr Biol 15:
24–30.
80. Stewart MJ, Berry CO, Zilberman F, Thomas G, Kozma SC (1996) The
Drosophila p70s6k homolog exhibits conserved regulatory elements and
rapamycin sensitivity. Proc Natl Acad Sci U S A 93: 10791–10796.
DHR3 Regulates dS6K-Dependent Growth
PLoS Genetics | www.plosgenetics.org 12 May 2010 | Volume 6 | Issue 5 | e1000937